Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Invesco KBW Bank ETF
KBWB
$6.73B
| $16M | 0.01% |
274,760
-36,211
| -12% | -$2M |
|
1077
PUT
Halliburton
HAL
$26.6B
| $16M | 0.01% |
653,600
+14,900
| +2% | +$314K |
|
1078
PUT
Dick's Sporting Goods
DKS
$18.7B
| $16M | 0.01% |
322,900
+900
| +0.3% | +$38.3K |
|
1079
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $16M | 0.01% |
359,304
-14,123
| -4% | -$598K |
|
|
IAA
1080
DELISTED
IAA, Inc. Common Stock
IAA
| $15.9M | 0.01% |
337,831
+251,362
| +291% | +$10.6M |
|
1081
CALL
Acadia Pharmaceuticals
ACAD
$5.03B
| $15.9M | 0.01% |
371,500
+15,600
| +4% | +$679K |
|
1082
ACI Worldwide
ACIW
$5.42B
| $15.8M | 0.01% |
417,920
+333,661
| +396% | +$11.4M |
|
1083
CALL
Duke Energy
DUK
$97.3B
| $15.8M | 0.01% |
173,300
-10,600
| -6% | -$972K |
|
1084
PUT
Illumina
ILMN
$28.4B
| $15.8M | 0.01% |
48,830
-55,718
| -53% | -$16.9M |
|
1085
Bath & Body Works
BBWI
$4.1B
| $15.7M | 0.01% |
1,071,449
+176,974
| +20% | +$2.55M |
|
|
SPR
1086
DELISTED
Spirit AeroSystems
SPR
| $15.7M | 0.01% |
215,364
+109,030
| +103% | +$8.99M |
|
1087
CALL
Eaton
ETN
$174B
| $15.7M | 0.01% |
165,600
+22,300
| +16% | +$1.98M |
|
1088
CALL
Las Vegas Sands
LVS
$29.6B
| $15.7M | 0.01% |
227,000
-89,300
| -28% | -$5.57M |
|
1089
Whirlpool
WHR
$2.82B
| $15.7M | 0.01% |
106,138
-26,191
| -20% | -$3.95M |
|
1090
IPG Photonics
IPGP
$3.84B
| $15.6M | 0.01% |
107,923
+67,260
| +165% | +$9.36M |
|
1091
PUT
Vertex Pharmaceuticals
VRTX
$126B
| $15.6M | 0.01% |
71,400
+18,900
| +36% | +$3.83M |
|
|
XLNX
1092
CALL
DELISTED
Xilinx Inc
XLNX
| $15.6M | 0.01% |
159,800
+97,200
| +155% | +$9.13M |
|
1093
CALL
Marvell Technology
MRVL
$196B
| $15.6M | 0.01% |
587,800
+31,500
| +6% | +$798K |
|
1094
WIX.com
WIX
$2.52B
| $15.6M | 0.01% |
127,138
-3,934
| -3% | -$481K |
|
|
BCM
1095
DELISTED
iPath Pure Beta Broad Commodity ETN
BCM
| $15.6M | 0.01% |
533,998
| – | – |
|
1096
United States Oil Fund
USO
$1.67B
| $15.5M | 0.01% |
151,205
+57,035
| +61% | +$5.42M |
|
1097
PUT
Verizon
VZ
$196B
| $15.5M | 0.01% |
252,300
+102,600
| +69% | +$6.19M |
|
1098
CALL
Nutrien
NTR
$30.7B
| $15.5M | 0.01% |
323,200
-3,700
| -1% | -$179K |
|
1099
CALL
Pinduoduo
PDD
$131B
| $15.5M | 0.01% |
409,200
+142,700
| +54% | +$5.33M |
|
|
VRNT
1100
DELISTED
Verint Systems
VRNT
| $15.5M | 0.01% |
548,600
+212,265
| +63% | +$5.17M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.